Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-22 Sale | 2021-03-23 6:02 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 2,422 | $5.48 | $13,273 | 145,017 (Direct) | View |
| 2021-02-01 Sale | 2021-02-01 9:39 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 3,821 | $6.36 | $24,302 | 72,439 (Direct) | View |
| 2021-01-20 Sale | 2021-01-22 5:29 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 2,630 | $4.41 | $11,598 | 76,260 (Direct) | View |
| 2020-11-02 Sale | 2020-11-02 4:44 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 2,050 | $3.21 | $6,581 | 78,890 (Direct) | View |
| 2020-01-21 Sale | 2020-01-23 5:33 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 1,269 | $5.92 | $7,512 | 70,940 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-15 Option Award | 2024-05-17 9:00 pm | N/A N/A | MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer | 390,600 | $0 | 390,600 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 18,750 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:10 pm | N/A 2029-04-07 | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 87,500 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 163,767 | $0 | 0 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-03 4:56 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 75,000 | $0 | 147,439 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 4:21 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 10,000 | $0 | 80,940 (Direct) | View |